FIELD: chemistry.
SUBSTANCE: present invention relates to a method of forming polyplexes based on nucleic acids, which can be used in gene therapy as safe and non-toxic transfection agents. Method includes several stages. At first, two liquid streams are created, one of which contains a polymer which is a highly branched poly(aminoether) (HPAE); and the second is a nucleic acid component. Polymer in the first liquid stream is then brought into contact with the nucleic acid component in the second liquid stream. Result is a polyplex having a size and a charge suitable for therapeutic administration. At the last stage, the obtained polyplex is isolated and stabilized.
EFFECT: proposed method is reproducible and scalable and also enables to obtain homogeneous and stable polyplexes.
43 cl, 1 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS FOR CELL TRANSFECTION | 2019 |
|
RU2824596C2 |
IMPROVED POLYETHYLENIMINE POLYETHYLENE GLYCOL VECTORS | 2015 |
|
RU2771104C2 |
FORMULA FOR INTRODUCING RNA | 2019 |
|
RU2797147C2 |
PHARMACEUTICAL COMPOSITION CONTAINING AN ANIONIC DRUG, AND A METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2721558C2 |
CRYOPROTECTIVE AGENTS FOR PARTICLE-CONTAINING FORMULATIONS | 2019 |
|
RU2820713C2 |
PEGYLATED LIPOSOMES FOR IMMUNOUGEN-CODING RNA DELIVERY | 2012 |
|
RU2628705C2 |
COMPOSITION FOR RNA ADMINISTRATION | 2017 |
|
RU2746118C2 |
INCLUSION COMPLEXES-CONTAINING COMPOSITIONS | 2001 |
|
RU2288921C2 |
MODIFIED NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS AND USE THEREOF | 2012 |
|
RU2707251C2 |
MODIFIED NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS AND THEIR APPLICATION | 2012 |
|
RU2648950C2 |
Authors
Dates
2024-06-25—Published
2019-12-30—Filed